Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 01:27PM ET
263.31
Dollar change
+9.12
Percentage change
3.59
%
IndexS&P 500 P/E28.60 EPS (ttm)9.21 Insider Own2.18% Shs Outstand51.34M Perf Week6.30%
Market Cap13.52B Forward P/E21.21 EPS next Y12.41 Insider Trans-1.78% Shs Float50.23M Perf Month21.74%
Income474.62M PEG3.11 EPS next Q2.10 Inst Own101.29% Short Float3.83% Perf Quarter33.59%
Sales4.13B P/S3.27 EPS this Y3.07% Inst Trans3.21% Short Ratio3.47 Perf Half Y25.58%
Book/sh70.06 P/B3.76 EPS next Y12.88% ROA6.01% Short Interest1.92M Perf Year18.12%
Cash/sh5.50 P/C47.85 EPS next 5Y9.19% ROE14.44% 52W Range161.65 - 260.04 Perf YTD11.38%
Dividend Est.- P/FCF37.01 EPS past 5Y14.84% ROI7.12% 52W High1.26% Beta1.39
Dividend TTM- Quick Ratio1.16 Sales past 5Y12.89% Gross Margin33.56% 52W Low62.89% ATR (14)7.68
Dividend Ex-Date- Current Ratio1.52 EPS Y/Y TTM-3.17% Oper. Margin15.82% RSI (14)74.61 Volatility2.26% 3.07%
Employees21800 Debt/Eq0.87 Sales Y/Y TTM3.86% Profit Margin11.49% Recom2.00 Target Price265.40
Option/ShortYes / Yes LT Debt/Eq0.85 EPS Q/Q-0.65% Payout0.00% Rel Volume0.94 Prev Close254.19
Sales Surprise2.24% EPS Surprise2.42% Sales Q/Q-7.85% EarningsFeb 14 BMO Avg Volume555.07K Price263.31
SMA2011.93% SMA5015.70% SMA20027.68% Trades Volume326,478 Change3.59%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Downgrade Guggenheim Buy → Neutral
Sep-13-23Initiated TD Cowen Market Perform $212
Jul-10-23Downgrade Citigroup Buy → Neutral $260 → $225
Feb-23-23Upgrade Guggenheim Neutral → Buy $255
Jan-12-23Downgrade Jefferies Buy → Hold
Sep-30-22Upgrade Jefferies Hold → Buy $240
Aug-25-22Initiated Credit Suisse Outperform $285
Aug-04-22Downgrade Morgan Stanley Overweight → Equal-Weight $350 → $250
May-24-22Initiated Guggenheim Neutral
Apr-25-22Downgrade Jefferies Buy → Hold $370 → $280
Feb-29-24 02:00AM
Feb-26-24 08:41AM
Feb-21-24 10:40AM
08:00AM
Feb-20-24 01:15PM
08:08AM Loading…
08:08AM
Feb-15-24 01:00PM
10:54AM
12:38AM
Feb-14-24 08:06PM
09:30AM
09:30AM
08:09AM
07:19AM
07:00AM
08:20AM Loading…
Feb-13-24 08:20AM
Feb-09-24 09:15AM
Feb-01-24 10:08AM
Jan-29-24 08:00AM
Jan-27-24 09:00AM
Jan-24-24 04:30PM
Jan-23-24 04:30PM
Jan-18-24 09:10AM
Jan-16-24 08:00AM
08:00AM
Jan-12-24 02:02PM
09:00AM
Jan-08-24 08:00AM
Jan-02-24 09:00AM
Dec-19-23 08:01AM
08:00AM Loading…
Dec-18-23 08:00AM
Dec-13-23 08:29AM
Dec-12-23 08:00AM
Dec-08-23 11:30AM
Dec-07-23 01:53PM
Dec-05-23 07:29AM
Dec-02-23 01:05AM
Nov-29-23 07:57AM
Nov-28-23 08:00AM
Nov-27-23 08:30AM
Nov-22-23 03:04AM
Nov-20-23 08:34PM
Nov-17-23 06:45PM
08:40AM
Nov-16-23 12:59PM
08:00AM
Nov-13-23 09:04AM
Nov-10-23 12:11PM
Nov-09-23 05:14PM
08:00AM
01:33AM
Nov-08-23 03:20PM
10:59AM
09:30AM
08:54AM
08:26AM
07:06AM
07:00AM
Nov-06-23 10:27AM
Nov-01-23 10:01AM
09:13AM
Oct-25-23 08:06PM
Oct-24-23 12:10PM
Oct-23-23 10:10AM
Oct-19-23 08:00AM
Oct-16-23 08:30AM
08:00AM
Oct-11-23 08:00AM
Oct-10-23 09:10AM
Oct-05-23 12:55PM
Oct-02-23 11:35AM
Sep-27-23 12:04PM
Sep-26-23 08:02AM
08:00AM
Sep-25-23 11:40AM
08:00AM
Sep-21-23 11:36AM
Sep-20-23 08:30AM
Sep-18-23 12:03PM
Sep-15-23 08:36AM
Sep-14-23 08:00AM
Sep-12-23 11:33AM
Sep-11-23 08:00AM
Sep-08-23 11:30AM
Sep-06-23 03:02PM
10:35AM
08:00AM
Aug-30-23 07:32PM
05:40PM
Aug-24-23 06:24PM
08:00AM
Aug-10-23 01:42PM
Aug-09-23 02:50PM
12:33PM
12:13PM
11:12AM
09:30AM
08:29AM
08:15AM
07:10AM
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Barbo William DCorporate Executive VP & CCOFeb 22Sale248.504,0501,006,42522,879Feb 23 04:57 PM
Parisotto Shannon MCEVP, Disc & Safety AssessmentFeb 15Option Exercise144.675,882850,9498,478Feb 20 05:32 PM
Parisotto Shannon MCEVP, Disc & Safety AssessmentFeb 15Sale241.205,8821,418,7672,596Feb 20 05:32 PM
LaPlume Joseph WEVP, Corp Strategy & DevelopFeb 15Sale238.93838200,22324,620Feb 20 05:20 PM
FOSTER JAMES CChairman, President and CEOJan 29Option Exercise144.6717,4362,522,466227,827Jan 31 04:59 PM
Girshick BirgitCorporate Executive VP & COOJan 10Option Exercise215.195,9161,273,06450,365Jan 11 04:09 PM
Creamer Victoria LEVP & Chief People OfficerDec 14Option Exercise136.705,526755,38822,032Dec 18 04:07 PM
Creamer Victoria LEVP & Chief People OfficerDec 14Sale225.005,5261,243,35016,506Dec 18 04:07 PM
LaPlume Joseph WEVP, Corp Strategy & DevelopNov 30Sale197.731,850365,80023,133Dec 01 04:10 PM
Girshick BirgitCorporate Executive VP & COONov 20Buy187.821,322248,29844,449Nov 21 05:07 PM
FOSTER JAMES CChairman, President and CEONov 14Buy178.055,6201,000,641202,643Nov 15 09:23 AM
LaPlume Joseph WEVP, Corp Strategy & DevelopNov 09Option Exercise144.679,1281,320,54834,111Nov 13 04:12 PM
LaPlume Joseph WEVP, Corp Strategy & DevelopNov 09Sale173.489,1281,583,52224,983Nov 13 04:12 PM
WALLMAN RICHARD FDirectorAug 24Buy198.791,000198,7861,000Aug 29 04:23 PM
Barbo William DCorporate Executive VP & CCOAug 10Option Exercise144.675,511797,2769,103Aug 14 04:17 PM
Knell Michael GunnarCSVP&Chief Accounting OfficerAug 10Option Exercise144.671,471212,81011,411Aug 14 04:15 PM
Barbo William DCorporate Executive VP & CCOAug 10Sale217.245,7631,251,9543,592Aug 14 04:17 PM
Knell Michael GunnarCSVP&Chief Accounting OfficerAug 10Sale216.541,471318,5309,940Aug 14 04:15 PM
LaPlume Joseph WEVP, Corp Strategy & DevelopAug 10Sale216.52700151,56424,983Aug 14 04:11 PM
LaPlume Joseph WEVP, Corp Strategy & DevelopMay 15Sale190.3934565,68524,026May 16 02:18 PM
LaPlume Joseph WEVP, Corp Strategy & DevelopMay 12Sale193.03959185,11624,371May 15 02:49 PM
MASSARO GEORGEDirectorMay 11Sale193.4328855,7084,964May 15 02:42 PM